Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Return on Equity (2016 - 2024)

Historic Return on Equity for KalVista Pharmaceuticals (KALV) over the last 8 years, with Q4 2024 value amounting to 0.57%.

  • KalVista Pharmaceuticals' Return on Equity changed N/A to 0.57% in Q4 2024 from the same period last year, while for Dec 2024 it was 0.57%, marking a year-over-year change of. This contributed to the annual value of 0.32% for FY2020, which is 100.0% up from last year.
  • According to the latest figures from Q4 2024, KalVista Pharmaceuticals' Return on Equity is 0.57%.
  • KalVista Pharmaceuticals' 5-year Return on Equity high stood at 0.14% for Q1 2021, and its period low was 0.74% during Q4 2024.
  • Its 3-year average for Return on Equity is 0.44%, with a median of 0.44% in 2020.
  • As far as peak fluctuations go, KalVista Pharmaceuticals' Return on Equity tumbled by -2400bps in 2020, and later soared by 3000bps in 2021.
  • Over the past 3 years, KalVista Pharmaceuticals' Return on Equity (Quarter) stood at 0.3% in 2020, then skyrocketed by 54bps to 0.14% in 2021, then tumbled by -310bps to 0.57% in 2024.
  • Its Return on Equity stands at 0.57% for Q4 2024, versus 0.74% for Q4 2024 and 0.6% for Q3 2024.